TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jonel Pasula Reumatolog AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 21 | 29 | 11 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 15 | -11 | -16 |
EBITDA | 6 | -11 | -16 |
Total assets | 503 | 615 | 793 |
Current assets | 504 | 615 | 793 |
Current liabilities | 319 | 333 | 473 |
Equity capital | 175 | 270 | 303 |
- share capital | 67 | 67 | 73 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 34.8% | 43.9% | 38.2% |
Turnover per employee | 21 | 29 | 11 |
Profit as a percentage of turnover | 71.4% | -37.9% | -145.5% |
Return on assets (ROA) | 3.0% | -1.8% | -2.0% |
Current ratio | 158.0% | 184.7% | 167.7% |
Return on equity (ROE) | 8.6% | -4.1% | -5.3% |
Change turnover | -8 | 19 | -17 |
Change turnover % | -27% | 193% | -61% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.